Alert

ID / ATT Name Matching Update: If the name on your IDs (including your middle name/middle initial) and your ATT does not match as described in the NAPLEX/MPJE Registration Bulletin, send a scanned copy of your primary ID with the name that should be on your ATT via e-mail to custserv@nabp.net. Acceptable primary IDs include US/Canadian passport, US/Canadian driver’s license, US state/Canadian province ID, and US/Canadian military ID. Your information will be updated in 48 hours and you will receive a confirmation e-mail. Please note that you must submit the name update at least 5 business days prior to the date of your scheduled examination or you will be turned away at the test center. There are no exceptions to this policy. If you are scheduled to test in less than 5 days, please see the NAPLEX/MPJE Registration Bulletin for details on rescheduling your exam.

Close

Federal Legislation to Prevent Prescription Drug Abuse Introduced to Senate

Topics: Controlled substances and Prescription drug abuse

Aimed to address prescription drug misuse, addiction, and overdose deaths, the Prescription Drug Abuse Prevention and Treatment Act (SB 348) was reintroduced in the United States Senate by Senator Jay Rockefeller (D-WV) and Representative Nick Rahall (D-WV). The bill includes a number of provisions aimed to prevent diversion and abuse and foster safe use of prescription drugs. Under the law, health care providers would be required to complete new training before obtaining a license to prescribe certain prescription pain killers. The implementation of consumer education on safe medication use would also be required. The bill also includes provisions for increased funding of state prescription monitoring programs. More information about the bill is available in a press release from the office of Senator Rockefeller. Similar legislation was introduced in 2011, but never came up for a vote in the Senate, reports the San Francisco Chronicle